Lanean...
Identification of cisplatin-binding sites on the large cytoplasmic loop of the Na(+)/K(+)-ATPase
Cisplatin is the most widely used chemotherapeutic drug for the treatment of various types of cancer; however, its administration brings also numerous side effects. It was demonstrated that cisplatin can inhibit the Na(+)/K(+)-ATPase (NKA), which can explain a large part of the adverse effects. In t...
Gorde:
| Argitaratua izan da: | J Enzyme Inhib Med Chem |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6009960/ https://ncbi.nlm.nih.gov/pubmed/29577756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2018.1445735 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|